The A. Alfred Taubman Medical Research Institute supports some of today’s most aggressive medical science researchers, all members of the University of Michigan Medical School faculty, with three-year grants that they use to fund their investigations.
These clinician-scientists and their laboratory teams are working to combat a wide array of diseases: childhood and adult cancer, neurodegentative diseases, diabetes, ALS, cardiovascular disease, obesity and many other debilitating conditions.
Scholars also serve as advocates for research by taking part in U-M efforts to educate the public about the importance of biomedical research and the need to provide support for scientific study.
Founding Taubman Scholars
The original Taubman Scholars, they continue to serve as leaders and advisers to the institute.
- Valerie P. Castle, M.D.
- Eva L. Feldman, M.D., Ph.D., F.A.A.N.
- David J. Pinsky, M.D.
- Max S. Wicha, M.D.
Senior Taubman Scholars
Through the progress of their research and their public stewardship of the cause of medical science, these former Taubman Scholars have earned renewed funding.
- Nicholas Boulis, M.D.
- Frank C. Brosius III, M.D.
- Charles F. Burant, M.D., Ph.D.
- Arul M. Chinnaiyan, M.D., Ph.D.
- David Ginsburg, M.D.
- Theodore Lawrence, M.D., Ph.D.
The Taubman Scholars are senior level physician-researchers and thought leaders in discovery-driven science.
- John Carethers, M.D.
- Kathleen Collins, M.D., Ph.D.
- Sharlene Day, M.D.
- Thomas Gardner, M.D., M.S.
- Henry L. Paulson, M.D.
- Pavan Reddy, M.D.
- Benjamin Segal, M.D.
- Jon-Kar Zubieta, M.D., Ph.D.
Taubman Emerging Scholars
The Emerging Scholars Program provides support for clinician-scientists on the U-M faculty who are in the early stages of their research careers.
There is a pressing need in the scientific community to do more to support early-career researchers who are increasingly choosing to leave the laboratory due to financial pressures. We are at risk of losing the next generation of our best and brightest scientists.
The Emerging Scholars Program offers an opportunity for them to establish their credentials in order to secure traditional funding in the future. They are aggresive "high risk, high reward" scientists who already have initatied a number of human clinical trials of new therapies for disease.
- Asheesh Bedi, M.D.
- Ronald J. Buckanovich, M.D., Ph.D.
- Sung Won Choi, M.D.
- Bradley Foerster, M.D., Ph.D
- Katherine Gallagher, M.D.
- Johann E. Gudjonsson, M.D., Ph.D.
- Alon Kahana, M.D., Ph.D.
- Brian J. Mickey, M.D., Ph.D.
- Erika A. Newman, M.D.
- Parag Patil, M.D., Ph.D.
- Srijan Sen, M.D., Ph.D.
- Scott Tomlins, M.D., Ph.D.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.